SB-86

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSB-86
Drug Alias NameSB-86
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhospholipase A2 group IIA inhibitors
TargetsPhospholipase A2 group IIA
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A